HEI:XETRHeidelberg Materials AG Analysis
Data as of 2026-09-05 - not real-time
$325.48
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
At $325.48, HEICO Corporation shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has lost 6.9%. Relative strength is 30.8 — approaching oversold — and the MACD signal is bearish. The recent range runs from support at $320.22 up to resistance at $376.07.
The shares look overvalued, trading on 54.3 times earnings above a sector average of 28.5. The average analyst target implies 21.8% above today's level. Revenue is growing at 23.1% on a 16.4% profit margin. The 0.08% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 22.7%, a beta of 1.17 and a maximum drawdown of 27.1%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
The shares look overvalued, trading on 54.3 times earnings above a sector average of 28.5. The average analyst target implies 21.8% above today's level. Revenue is growing at 23.1% on a 16.4% profit margin. The 0.08% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 22.7%, a beta of 1.17 and a maximum drawdown of 27.1%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.
Top Market Events
HOLLYWOOD, FL AND MIAMI, FL / ACCESS Newswire / August 10, 2026 / On August 25, 2026, after the NYSE closing, HEICO...Heico HEI is well positioned to outperform the market, as it exhibits above-average growth in financials.Detailed price information for Heico Corp HEI-N from The Globe and Mail including charting and trades.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 322.66
- MACD momentum is negative
- 30-day price change of -6.9%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 54.3 versus sector average of 28.5
- Trading above the 200-day average of 322.66
- Analyst targets imply +21.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 54.3 versus sector average of 28.5
- Analyst targets imply +21.8% versus the current price
- Profit margin of 16.4% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth23.10%
Profit Margin16.38%
P/E Ratio54.3
ROE17.73%
ROA8.50%
Debt/Equity45.03
P/B Ratio10.5
Op. Cash Flow$1.1B
Free Cash Flow$845.4M
Industry P/E28.5
Technical Analysis
TrendNeutral
RSI30.8
Support$320.22
Resistance$376.07
MA 20$350.62
MA 50$352.13
MA 200$322.66
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48
Valuation
Fair Value$178.03
Target Price$396.55
Upside/Downside21.84%
GradeOvervalued
TypeGrowth
Dividend Yield0.08%
Risk Assessment
Beta1.17
Volatility22.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.